SINTESIS DAN UJI AKTIVITAS PENGHAMBATAN POLIMERISASI HEM SENYAWA 3-HIDROKSI-6-METILSANTON

Synthesis of 3-hydroxy-6-methylxanthone from resorcinol and m-cresol has been conducted. Heme polymerization inhibitory activity assay of the synthesized antimalarial has also been carried out. Synthesis of antimalarial of xanthone derivative was conducted in two steps. The first step of reaction wa...

全面介紹

Saved in:
書目詳細資料
Main Authors: , PRESTIKA GEMA SARI, , Prof. Dr. Jumina
格式: Theses and Dissertations NonPeerReviewed
出版: [Yogyakarta] : Universitas Gadjah Mada 2014
主題:
ETD
在線閱讀:https://repository.ugm.ac.id/129625/
http://etd.ugm.ac.id/index.php?mod=penelitian_detail&sub=PenelitianDetail&act=view&typ=html&buku_id=70019
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
機構: Universitas Gadjah Mada
實物特徵
總結:Synthesis of 3-hydroxy-6-methylxanthone from resorcinol and m-cresol has been conducted. Heme polymerization inhibitory activity assay of the synthesized antimalarial has also been carried out. Synthesis of antimalarial of xanthone derivative was conducted in two steps. The first step of reaction was carboxylation of resorcinol via Kolbe reaction, resorcinol was refluxed with aqueous solution of potassium bicarbonate in the presence of carbon dioxide (CO2) then acidified by hydrogen chloride to provide 2,4-dihydroybenzoic acid compound in the form of a white solid with percent yield and melting point respectively 40.64% and 213.7â��217.6 °C. The final step, carboxylation product 2,4-dihydroxybenzoic acid was reacted with m-cresol. The mixture was heated with Eatonâ��s reagent at 70â��80 °C for 3 hours to yield 3-hydroxy-6-methylxanthone (76.7%) as a brown oily solid. The structures of products were characterized by IR, MS and 1H-NMR spectrometers. The results of heme polymerization inhibitory activity assay of 6-hydroxy-3-methylxanthone was determined by standard curve as the reference. The results showed that 3-hydroxy-6-methylxanthone had IC50 HPIA of 8.85 Ã� 10-3 mM, while chloroquine had IC50 0.172 mM. These results indicated that 3-hydroxy-6-methylxanthone is a potential antimalarial agent rather than chloroquine 0.172 mM